# Incyte
> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.
## Record
| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:590d6dea-9be2-46bc-8fbc-41ed972808f7 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/incyte-corp |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 43 |
| Claims under review | 1 |
| Evidence records | 16 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-16T13:51:36.651657+00:00 |
| Last reviewed | 2026-10-16T13:51:36.651657+00:00 |
## Identity
- Legal name: INCYTE CORP
- Display name: Incyte
## Alpha Governance Record
| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-16T16:02:32.718615+00:00 |
| Completeness | 0.455 |
| Record Quality | 0.837 |
| Directors | 9 |
| Committees | 8 |
| Governance events | 28 |
| Entity class | public_company |
## Section coverage
| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | PUBLISHED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |
## Board
- Edmund P. Harrigan, M.D.: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Audit and Finance (member); Science and Technology (chair); Science and Technology · Chair; Audit and Finance (member). claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:10
- Jacqualyn A. Fouse, Ph.D.: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Audit and Finance (member); Audit and Finance; Nominating and Corporate Governance (member); Nominating and Corporate Governance (member). claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:11
- Jean-Jacques Bienaim: Independent Director. Status: current. Independent: true. Since: 2015-01-01. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:12
- Julian C. Baker: Chair. Status: current. Independent: false. Since: 2001-01-01. Committees: Compensation (member); Nominating and Corporate Governance (chair); Nominating and Corporate Governance · Chair; Compensation (chair). claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:9
- Katherine A. High, M.D.: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Science and Technology (member). claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:13
- Otis W. Brawley: Independent Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Science and Technology (member). claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:14
- Paul J. Clancy: Independent Director. Status: current. Independent: true. Since: 2015-01-01. Committees: Audit and Finance (chair); Audit and Finance · Chair; Compensation (member); Compensation (member). claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:15
- William J. Meury: Director. Status: current. Independent: false. Since: 2025-01-01. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:16
- Susanne Schaffert, Ph.D.: Director (committee appointment). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. Committees: Compensation (member). claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_record:32
## Committees
- Audit and Finance (audit). Chair: Paul J. Clancy. Members: Paul J. Clancy (chair, current); Edmund P. Harrigan, M.D. (member, current); Jacqualyn A. Fouse, Ph.D. (member, current). committee_id=alpha:committee:incyte-corp:audit-and-finance
- Audit and Finance · Chair; Compensation (audit). Chair: NOT_PUBLISHED. Members: Paul J. Clancy (member, current). committee_id=alpha:committee:incyte-corp:audit-and-finance-chair-compensation
- Audit and Finance; Nominating and Corporate Governance (audit). Chair: NOT_PUBLISHED. Members: Jacqualyn A. Fouse, Ph.D. (member, current). committee_id=alpha:committee:incyte-corp:audit-and-finance-nominating-and-corporate-governance
- Compensation (compensation). Chair: NOT_PUBLISHED. Members: Julian C. Baker (member, current); Paul J. Clancy (member, current); Susanne Schaffert, Ph.D. (member, current). committee_id=alpha:committee:incyte-corp:compensation
- Nominating and Corporate Governance (nominating_governance). Chair: Julian C. Baker. Members: Julian C. Baker (chair, current); Jacqualyn A. Fouse, Ph.D. (member, current). committee_id=alpha:committee:incyte-corp:nominating-and-corporate-governance
- Nominating and Corporate Governance · Chair; Compensation (compensation). Chair: Julian C. Baker. Members: Julian C. Baker (chair, current). committee_id=alpha:committee:incyte-corp:nominating-and-corporate-governance-chair-compensation
- Science and Technology (technology). Chair: Edmund P. Harrigan, M.D.. Members: Edmund P. Harrigan, M.D. (chair, current); Katherine A. High, M.D. (member, current); Otis W. Brawley (member, current). committee_id=alpha:committee:incyte-corp:science-and-technology
- Science and Technology · Chair; Audit and Finance (audit). Chair: NOT_PUBLISHED. Members: Edmund P. Harrigan, M.D. (member, current). committee_id=alpha:committee:incyte-corp:science-and-technology-chair-audit-and-finance
## Executive leadership
- David Gardner: Executive Vice President and Chief Strategy Officer. Status: current. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:17
- Lee Heeson: Executive Vice President, Incyte International. Status: current. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:18
- Matteo Trotta: Executive Vice President, General Manager, Dermatology US. Status: current. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:19
- Michael Morrissey: Executive Vice President and Head of Global Technical Operations. Status: current. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:20
- Mohamed Issa: Executive Vice President, Head of US Oncology. Status: current. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:21
- Pablo J. Cagnoni: President and Head of Research and Development [PRESIDENT]. Status: current. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:22
- Reid G. Hoffman: Executive Vice President and General Counsel [GC]. Status: current. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:23
- Soni Basi: Executive Vice President and Chief Human Resources Officer [CHRO]. Status: current. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:25
- Steven Stein: Executive Vice President and Chief Medical Officer. Status: current. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:26
- William J. Meury: President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:27
- Richard Hoffman: Executive Vice President and General Counsel [GC]. Status: unknown. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:24
## Governance events
- EXECUTIVE_APPOINTED: David Gardner executive of Incyte, effective 2026-02-10. Effective: 2026-02-10. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:l0rk0u1v7xpd8
- EXECUTIVE_APPOINTED: Lee Heeson executive of Incyte, effective 2026-02-10. Effective: 2026-02-10. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:1hqnhjb16zyhm1
- EXECUTIVE_APPOINTED: Matteo Trotta executive of Incyte, effective 2026-02-10. Effective: 2026-02-10. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:1wq6k72zotzxq
- EXECUTIVE_APPOINTED: Michael Morrissey executive of Incyte, effective 2026-02-10. Effective: 2026-02-10. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:10zo14k1oyvw96
- EXECUTIVE_APPOINTED: Mohamed Issa executive of Incyte, effective 2026-02-10. Effective: 2026-02-10. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:1l5rubq13wvvza
- EXECUTIVE_APPOINTED: Pablo J. Cagnoni executive of Incyte, effective 2026-02-10. Effective: 2026-02-10. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:1xze6qs1t8xu1m
- GC_CHANGED: Reid G. Hoffman executive of Incyte, effective 2026-02-10. Effective: 2026-02-10. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:wtfemy15dtqs
- EXECUTIVE_APPOINTED: Soni Basi executive of Incyte, effective 2026-02-10. Effective: 2026-02-10. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:1xljo607fkweq
- EXECUTIVE_APPOINTED: Steven Stein executive of Incyte, effective 2026-02-10. Effective: 2026-02-10. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:12vxect4t347p
- CEO_CHANGED: William J. Meury executive of Incyte, effective 2026-02-10. Effective: 2026-02-10. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:121ciesypmsqe
- DIRECTOR_APPOINTED: William J. Meury seat on Incyte, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:amgx6q16jq02i
- DIRECTOR_APPOINTED: Otis W. Brawley seat on Incyte, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:l64despqlxw4
- DIRECTOR_APPOINTED: Katherine A. High, M.D. seat on Incyte, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:sqiwq0n2i4dq
- COMMITTEE_MEMBER_ADDED: Katherine A. High, M.D. member of Science and Technology, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:efnuys13gbchy
- DIRECTOR_APPOINTED: Edmund P. Harrigan, M.D. seat on Incyte, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:4dch191px262f
- COMMITTEE_CREATED: Science and Technology · Chair; Audit and Finance committee of Incyte, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:1csrpkx15v9rwv
- COMMITTEE_MEMBER_ADDED: Edmund P. Harrigan, M.D. member of Science and Technology · Chair; Audit and Finance, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:1p9y2b7ns59b5
- DIRECTOR_APPOINTED: Jacqualyn A. Fouse, Ph.D. seat on Incyte, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:1v4ky2waxtwm4
- COMMITTEE_CREATED: Audit and Finance; Nominating and Corporate Governance committee of Incyte, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:1o3vjpw10ag2s
- COMMITTEE_MEMBER_ADDED: Jacqualyn A. Fouse, Ph.D. member of Audit and Finance; Nominating and Corporate Governance, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:1yi5jhw1pxaz3q
- DIRECTOR_APPOINTED: Jean-Jacques Bienaim seat on Incyte, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:141br331ea9hbl
- DIRECTOR_APPOINTED: Paul J. Clancy seat on Incyte, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:172vvxyaxv0ai
- COMMITTEE_CREATED: Audit and Finance · Chair; Compensation committee of Incyte, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:40k85e1cy0yy2
- COMMITTEE_MEMBER_ADDED: Paul J. Clancy member of Audit and Finance · Chair; Compensation, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:q7jfubiz08lp
- DIRECTOR_APPOINTED: Julian C. Baker seat on Incyte, effective 2001-01-01. Effective: 2001-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:hpiidi1g8sfbu
- BOARD_CHAIR_CHANGED: Julian C. Baker chairs board Incyte, effective 2001-01-01. Effective: 2001-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:v162vw1nhwgza
- COMMITTEE_CREATED: Nominating and Corporate Governance · Chair; Compensation committee of Incyte, effective 2001-01-01. Effective: 2001-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:7lojp07i6jna
- COMMITTEE_CHAIR_CHANGED: Julian C. Baker chairs Nominating and Corporate Governance · Chair; Compensation, effective 2001-01-01. Effective: 2001-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:qxrue613rzjpu
## Scoped resources
- `alpha://company/incyte-corp` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record
- `alpha://company/incyte-corp/identity` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=identity
- `alpha://company/incyte-corp/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=corporate-structure
- `alpha://company/incyte-corp/board` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=board
- `alpha://company/incyte-corp/committees` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=committees
- `alpha://company/incyte-corp/leadership` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=leadership
- `alpha://company/incyte-corp/ownership` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=ownership
- `alpha://company/incyte-corp/financials` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=financials
- `alpha://company/incyte-corp/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=capital-structure
- `alpha://company/incyte-corp/compensation` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=compensation
- `alpha://company/incyte-corp/governance` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=governance
- `alpha://company/incyte-corp/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=shareholder-governance
- `alpha://company/incyte-corp/audit` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=audit
- `alpha://company/incyte-corp/legal` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=legal
- `alpha://company/incyte-corp/risk` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=risk
- `alpha://company/incyte-corp/cyber` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=cyber
- `alpha://company/incyte-corp/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=ai-governance
- `alpha://company/incyte-corp/agents` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=agents
- `alpha://company/incyte-corp/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=ecosystem
- `alpha://company/incyte-corp/events` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=events
- `alpha://company/incyte-corp/relationships` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=relationships
- `alpha://company/incyte-corp/assessments` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=assessments
- `alpha://company/incyte-corp/evidence` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=evidence
## Role modules
- NOT_ASSERTED
## Attention
- NO_RECORDS_FOUND
## Committee data
- Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:29: `{"kind":"committee_appointment","original_name":"Audit and Finance","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:paul-j-clancy","name":"Paul J. Clancy"},"source_id":"board_seats"}`
- Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:30: `{"kind":"committee_appointment","original_name":"Audit and Finance","category":"audit","role":"member","person":{"alpha_id":"alpha:person:edmund-p-harrigan-md","name":"Edmund P. Harrigan, M.D."},"source_id":"board_seats"}`
- Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:31: `{"kind":"committee_appointment","original_name":"Audit and Finance","category":"audit","role":"member","person":{"alpha_id":"alpha:person:jacqualyn-a-fouse-phd","name":"Jacqualyn A. Fouse, Ph.D."},"source_id":"board_seats"}`
- Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:33: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:julian-c-baker","name":"Julian C. Baker"},"source_id":"board_seats"}`
- Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:34: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:paul-j-clancy","name":"Paul J. Clancy"},"source_id":"board_seats"}`
- Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:35: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:susanne-schaffert-phd","name":"Susanne Schaffert, Ph.D."},"source_id":"board_seats"}`
- Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:37: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:julian-c-baker","name":"Julian C. Baker"},"source_id":"board_seats"}`
- Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:38: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:jacqualyn-a-fouse-phd","name":"Jacqualyn A. Fouse, Ph.D."},"source_id":"board_seats"}`
- Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:40: `{"kind":"committee_appointment","original_name":"Science and Technology","category":"technology","role":"chair","person":{"alpha_id":"alpha:person:edmund-p-harrigan-md","name":"Edmund P. Harrigan, M.D."},"source_id":"board_seats"}`
- Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:41: `{"kind":"committee_appointment","original_name":"Science and Technology","category":"technology","role":"member","person":{"alpha_id":"alpha:person:katherine-a-high-md","name":"Katherine A. High, M.D."},"source_id":"board_seats"}`
- Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:42: `{"kind":"committee_appointment","original_name":"Science and Technology","category":"technology","role":"member","person":{"alpha_id":"alpha:person:otis-w-brawley","name":"Otis W. Brawley"},"source_id":"board_seats"}`
## Leadership
- Julian C. Baker: Chair, Nominating and Corporate Governance · Chair; Compensation. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:9. Valid from: 2001-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6b5fe7cd264d2c97859641abe6627e404142155a3b752ca81e02401f790a0d28.
- Edmund P. Harrigan, M.D.: Director, Science and Technology · Chair; Audit and Finance. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:10. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6b5fe7cd264d2c97859641abe6627e404142155a3b752ca81e02401f790a0d28.
- Jacqualyn A. Fouse, Ph.D.: Director, Audit and Finance; Nominating and Corporate Governance. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:11. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6b5fe7cd264d2c97859641abe6627e404142155a3b752ca81e02401f790a0d28.
- Jean-Jacques Bienaim: Independent Director. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:12. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6b5fe7cd264d2c97859641abe6627e404142155a3b752ca81e02401f790a0d28.
- Katherine A. High, M.D.: Director, Science and Technology. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:13. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6b5fe7cd264d2c97859641abe6627e404142155a3b752ca81e02401f790a0d28.
- Otis W. Brawley: Independent Director, Science and Technology. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:14. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6b5fe7cd264d2c97859641abe6627e404142155a3b752ca81e02401f790a0d28.
- Paul J. Clancy: Independent Director, Audit and Finance · Chair; Compensation. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:15. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6b5fe7cd264d2c97859641abe6627e404142155a3b752ca81e02401f790a0d28.
- William J. Meury: Director. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:16. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6b5fe7cd264d2c97859641abe6627e404142155a3b752ca81e02401f790a0d28.
- David Gardner: Executive Vice President and Chief Strategy Officer. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:17. Valid from: 2026-02-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:19f1fdfd1ee09449cf6ef33c48f330ec2ed6d0c82ba2af5b2e0ebbe3c5c03166.
- Lee Heeson: Executive Vice President, Incyte International. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:18. Valid from: 2026-02-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5d72178e5acd07aa1b3af0ba6ee37f8cdd0ec941159c4f328a0ec0f0e279eb3b.
- Matteo Trotta: Executive Vice President, General Manager, Dermatology US. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:19. Valid from: 2026-02-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5f087e9b492de92b63909fcbf886cbc0d603e869872a80e4e47897937413f872.
- Michael Morrissey: Executive Vice President and Head of Global Technical Operations. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:20. Valid from: 2026-02-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cca17f96a15a91fa76387c8abaf889e19cf0e8c6beda7681e223c1ba5fd48d0e.
- Mohamed Issa: Executive Vice President, Head of US Oncology. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:21. Valid from: 2026-02-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eadb8394e7c5c0fe4a637268f2e0e5bbce8cb3a1420d67882ff98ef8caaddc9d.
- Pablo J. Cagnoni: President and Head of Research and Development. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:22. Valid from: 2026-02-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3b19e74569bb098ce52a5e6fc598f6c167b0ff10ae9c1c82337e452d0a83fc84.
- Reid G. Hoffman: Executive Vice President and General Counsel. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:23. Valid from: 2026-02-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a1791f61d598804fb43f93575c55243d952a18ce1eb644507d3b08874590be8c.
- Richard Hoffman: Executive Vice President and General Counsel. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:df47b510d310a673fcd2e632e54310a5f44246d1af1676fc9161ce64adcc9458.
- Soni Basi: Executive Vice President and Chief Human Resources Officer. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:25. Valid from: 2026-02-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:77dec150864caa31feb00354e2e71a80fac1c5d03af75f5d5336283c9229f85c.
- Steven Stein: Executive Vice President and Chief Medical Officer. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:26. Valid from: 2026-02-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:802f4ccba8f7ec17c7c5144efbb0f6b31db4252ca74747fd864d4116ae22995c.
- William J. Meury: President and Chief Executive Officer. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:27. Valid from: 2026-02-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ca0626aeb5750f9f29106e069106b2b16e440dcb5f6aaf1f66b1aa6f62b5cdf3.
## Roles
- PUBLISHED
## Governance
- NOT_ASSERTED
## Board committees
- Audit and Finance: Chair Paul J. Clancy; Members Paul J. Clancy (Chair); Edmund P. Harrigan, M.D.; Jacqualyn A. Fouse, Ph.D.. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_record:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325.
- Compensation: Chair not stated; Members Julian C. Baker; Paul J. Clancy; Susanne Schaffert, Ph.D.. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_record:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325.
- Nominating and Corporate Governance: Chair Julian C. Baker; Members Julian C. Baker (Chair); Jacqualyn A. Fouse, Ph.D.. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_record:36. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325.
- Science and Technology: Chair Edmund P. Harrigan, M.D.; Members Edmund P. Harrigan, M.D. (Chair); Katherine A. High, M.D.; Otis W. Brawley. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_record:39. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325.
## Financials
- NOT_ASSERTED
## Workforce
- NOT_ASSERTED
## Market and index context
- S&P 500 (SPX). Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:index_membership:43. Valid from: 2017-02-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:827a22a1567eda11fa866650563f33918ee2975144378fa7fd6f46399da5427a.
## Legal Name
- INCYTE CORP. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0ea56fd0c183e351bb42f2a564927b7db48ed75d23e5c57d9a5322f07a22fb55.
## Entity Status
- Public listing published. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0ea56fd0c183e351bb42f2a564927b7db48ed75d23e5c57d9a5322f07a22fb55.
## Official Website
- https://www.incyte.com. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:official_website:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7bc3dc35da3c0a2209c493dc6566128ac682e8b3329f7a032b473eb48297de70.
## Published Fact
- US. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0ea56fd0c183e351bb42f2a564927b7db48ed75d23e5c57d9a5322f07a22fb55.
- DE. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0ea56fd0c183e351bb42f2a564927b7db48ed75d23e5c57d9a5322f07a22fb55.
- Healthcare. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:published_fact:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0ea56fd0c183e351bb42f2a564927b7db48ed75d23e5c57d9a5322f07a22fb55.
- https://www.incyte.com. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:published_fact:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7bc3dc35da3c0a2209c493dc6566128ac682e8b3329f7a032b473eb48297de70.
## Committee Appointment
- Paul J. Clancy: chair, Audit and Finance. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325.
- Edmund P. Harrigan, M.D.: member, Audit and Finance. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325.
- Jacqualyn A. Fouse, Ph.D.: member, Audit and Finance. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325.
- Julian C. Baker: member, Compensation. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325.
- Paul J. Clancy: member, Compensation. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:34. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325.
- Susanne Schaffert, Ph.D.: member, Compensation. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:35. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325.
- Julian C. Baker: chair, Nominating and Corporate Governance. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:37. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325.
- Jacqualyn A. Fouse, Ph.D.: member, Nominating and Corporate Governance. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:38. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325.
- Edmund P. Harrigan, M.D.: chair, Science and Technology. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:40. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325.
- Katherine A. High, M.D.: member, Science and Technology. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:41. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325.
- Otis W. Brawley: member, Science and Technology. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:42. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325.
## Security Listing
- INCY (NASDAQ). Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:security_listing:44. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0ea56fd0c183e351bb42f2a564927b7db48ed75d23e5c57d9a5322f07a22fb55.
## Coverage states
| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |
## Public sources
- alpha:projection-evidence:0ea56fd0c183e351bb42f2a564927b7db48ed75d23e5c57d9a5322f07a22fb55: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/incyte-corp).
- alpha:projection-evidence:7bc3dc35da3c0a2209c493dc6566128ac682e8b3329f7a032b473eb48297de70: [INCYTE CORP Form 10-K (filed 2026-02-10)](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm).
- alpha:projection-evidence:document:6b5fe7cd264d2c97859641abe6627e404142155a3b752ca81e02401f790a0d28: [Incyte Corporation DEF 14A 2026-04-28](https://www.sec.gov/Archives/edgar/data/879169/000087916926000031/incy-20260428.htm).
- alpha:projection-evidence:document:19f1fdfd1ee09449cf6ef33c48f330ec2ed6d0c82ba2af5b2e0ebbe3c5c03166: [INCY 10-K executive officers](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm).
- alpha:projection-evidence:document:5d72178e5acd07aa1b3af0ba6ee37f8cdd0ec941159c4f328a0ec0f0e279eb3b: [INCY 10-K executive officers](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm).
- alpha:projection-evidence:document:5f087e9b492de92b63909fcbf886cbc0d603e869872a80e4e47897937413f872: [INCY 10-K executive officers](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm).
- alpha:projection-evidence:document:cca17f96a15a91fa76387c8abaf889e19cf0e8c6beda7681e223c1ba5fd48d0e: [INCY 10-K executive officers](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm).
- alpha:projection-evidence:document:eadb8394e7c5c0fe4a637268f2e0e5bbce8cb3a1420d67882ff98ef8caaddc9d: [INCY 10-K executive officers](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm).
- alpha:projection-evidence:document:3b19e74569bb098ce52a5e6fc598f6c167b0ff10ae9c1c82337e452d0a83fc84: [INCY 10-K executive officers](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm).
- alpha:projection-evidence:document:a1791f61d598804fb43f93575c55243d952a18ce1eb644507d3b08874590be8c: [INCY 10-K executive officers](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm).
- alpha:projection-evidence:document:df47b510d310a673fcd2e632e54310a5f44246d1af1676fc9161ce64adcc9458: INCY executive roster source.
- alpha:projection-evidence:document:77dec150864caa31feb00354e2e71a80fac1c5d03af75f5d5336283c9229f85c: [INCY 10-K executive officers](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm).
- alpha:projection-evidence:document:802f4ccba8f7ec17c7c5144efbb0f6b31db4252ca74747fd864d4116ae22995c: [INCY 10-K executive officers](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm).
- alpha:projection-evidence:document:ca0626aeb5750f9f29106e069106b2b16e440dcb5f6aaf1f66b1aa6f62b5cdf3: [INCY 10-K executive officers](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm).
- alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325: [Audit and Finance](https://www.sec.gov/Archives/edgar/data/879169/000087916926000031/incy-20260428.htm).
- alpha:projection-evidence:827a22a1567eda11fa866650563f33918ee2975144378fa7fd6f46399da5427a: [S&P 500](https://www.slickcharts.com/sp500).
## Rights
| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |
## Limitations
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
## Alternate representations
- [Canonical profile](https://registry.alpha.ac/companies/incyte-corp)
- [Public Markdown](https://registry.alpha.ac/companies/incyte-corp.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/incyte-corp?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/incyte-corp?format=jsonld)
- MCP resource: `alpha://companies/incyte-corp` at https://mcp.alpha.ac/mcp
## Connected governance records
Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.
## Critical-risk oversight
Snapshot as of 2026-10-16T16:02:32.436973+00:00; recorded 2026-10-16T16:02:32.436973+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.Incyte, for agents
The same record as the human view, as a structured object any agent can read and cite. Reading is open to every agent, model, and tool, with no key and no account. Signing and transparency logging are not yet published for this record.
- Alpha ID
- alpha:company:590d6dea-9be2-46bc-8fbc-41ed972808f7
- Version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ceRecorded Oct 16, 2026
- Content hash
- Not yet signed
- Signature
- Not yet signed
- Transparency log
- Not yet signed
- Freshness
- ObservedChecked Oct 16, 2026. Reviewed Oct 16, 2026
- Read access
- OpenNo key for public retrieval
- Processing basis
- Public recordDoctrine
Read
OpenOne canonical URL. The Accept header or a file suffix selects the format. Every format renders the same Claims and carries the same record version.
curl -H "Accept: application/json" https://registry.alpha.ac/companies/incyte-corpTrustCheck and Governance Receipts
Agent tierIllustrative. TrustChecks run in the private enterprise overlay. The example below is generated for this entity class and does not reference this record. Contract: TrustCheck and Governance Receipts v0.1.
Agents about to act ask a question, not for a document. A TrustCheck evaluates the AuthorityGrant objects behind a proposed action and returns allow, deny, require_approval, or insufficient_evidence. The source system acts, and a GovernanceReceipt records what the agent relied on.
- allow, deny
- The AuthorityGrant and policy decide. Reason codes name the rule.
- require_approval
- An entitled human records the decision. Customer policy sets the threshold, never an Eval.
- insufficient_evidence
- No authority is registered. Alpha never infers permission to act.
curl https://www.alpha.ac/v1/action-intents \
-H 'Content-Type: application/json' \
-b "$ALPHA_SESSION_COOKIE" \
-d '{
"schema_version": "2026-08-29",
"environment": "test",
"actor": { "alpha_id": "alpha:account:self", "type": "alpha_account" },
"principal": { "alpha_id": "alpha:company:example-issuer", "type": "organization" },
"organization": { "alpha_id": "alpha:company:example-issuer", "type": "organization" },
"proposed_action": { "type": "purchase_order.commit", "description": "Accept an order placed by an agent claiming company authority." },
"requested_authority": ["purchase_order.commit"]
}'
# then
curl https://www.alpha.ac/v1/trust-checks -H 'Content-Type: application/json' \
-b "$ALPHA_SESSION_COOKIE" -d '{ "action_intent_id": "<from the previous response>" }'{
"schema_version": "2026-08-29",
"trust_check_id": "alpha:trust-check:illustrative-0001",
"decision": "insufficient_evidence",
"explanation": "No AuthorityGrant names this agent and organization.",
"reason_codes": [
"authority_grant_missing"
],
"evaluated_authority": {
"authority_grants": []
},
"policy_version": "trustcheck.registry-claim.test.v0.1",
"integrity_state": "recorded",
"limitations": [
"Illustrative example. No TrustCheck was run for this record."
]
}{
"schema_version": "2026-08-29",
"receipt_id": "alpha:receipt:illustrative-0001",
"environment": "test",
"actor": {
"alpha_id": "alpha:account:self",
"type": "alpha_account"
},
"agent": {
"provider": {
"alpha_id": "alpha:company:example-agent-provider",
"type": "provider"
},
"product": {
"alpha_id": "alpha:agent-product:example-procurement-agent",
"type": "agent_product"
},
"deployment": {
"alpha_id": "alpha:agent-deployment:example-deployment",
"type": "agent_deployment"
},
"use_case": {
"alpha_id": "alpha:agent-use-case:example-purchase-order",
"type": "agent_use_case"
},
"workflow": "Illustrative purchase order commitment"
},
"principal": {
"alpha_id": "alpha:company:example-issuer",
"type": "organization"
},
"sponsor": {
"alpha_id": "alpha:company:example-issuer",
"type": "organization"
},
"action_intent_id": "alpha:action-intent:illustrative-0001",
"trust_check_id": "alpha:trust-check:illustrative-0001",
"authority_grant_references": [],
"action_intent": {
"type": "purchase_order.commit"
},
"affected_alpha_ids": [
"alpha:company:example-issuer"
],
"trust_check_decision": "insufficient_evidence",
"policy_version": "trustcheck.registry-claim.test.v0.1",
"rule_references": [
{
"reason_code": "authority_grant_missing",
"rule_id": "trustcheck.authority_grant_missing",
"policy_ref": "trustcheck.registry-claim.test.v0.1",
"control_ref": null,
"grant_policy_references": []
}
],
"integrity": "Illustrative. Not issued, not signed."
}Connect
Open readEvery surface reads the same published record. No surface holds its own copy of the facts.
// claude_desktop_config.json, Cursor, or any MCP client
{
"mcpServers": {
"alpha": { "url": "https://mcp.alpha.ac/mcp" }
}
}
// This record as an MCP resource
alpha://companies/incyte-corpalpha://companies/incyte-corpThis record as an MCP resourcehttps://registry.alpha.ac/api/public/companies/incyte-corp?format=recordThe same record over HTTP
Subscribe to changes
Agent tier, previewNo public subscription endpoint is published yet. Event delivery is part of Agent tier access, in preview. Access and availability.
EXECUTIVE_APPOINTEDDerived governance event published on this record (alpha-governance-event-derivation-v2)GC_CHANGEDDerived governance event published on this record (alpha-governance-event-derivation-v2)CEO_CHANGEDDerived governance event published on this record (alpha-governance-event-derivation-v2)DIRECTOR_APPOINTEDDerived governance event published on this record (alpha-governance-event-derivation-v2)COMMITTEE_MEMBER_ADDEDDerived governance event published on this record (alpha-governance-event-derivation-v2)COMMITTEE_CREATEDDerived governance event published on this record (alpha-governance-event-derivation-v2)BOARD_CHAIR_CHANGEDDerived governance event published on this record (alpha-governance-event-derivation-v2)COMMITTEE_CHAIR_CHANGEDDerived governance event published on this record (alpha-governance-event-derivation-v2)
{
"specversion": "1.0",
"type": "ac.alpha.registry.EXECUTIVE_APPOINTED",
"source": "https://registry.alpha.ac/companies/incyte-corp",
"subject": "alpha:company:590d6dea-9be2-46bc-8fbc-41ed972808f7",
"data": {
"record_version": "public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce",
"note": "Subscription delivery is Agent tier, preview. Not yet available publicly."
}
}Versions and changes
OpenRecords are versioned. Derived governance events on this record are listed below with the version that publishes them. Effective is the world time the derivation states; Recorded is when Alpha detected the event. Content hashes and log entries appear once records are signed.
| Version | Effective | Recorded | Content hash | Log entry | What changed |
|---|---|---|---|---|---|
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Feb 10, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | David Gardner executive of Incyte, effective 2026-02-10. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Feb 10, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Lee Heeson executive of Incyte, effective 2026-02-10. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Feb 10, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Matteo Trotta executive of Incyte, effective 2026-02-10. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Feb 10, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Michael Morrissey executive of Incyte, effective 2026-02-10. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Feb 10, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Mohamed Issa executive of Incyte, effective 2026-02-10. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Feb 10, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Pablo J. Cagnoni executive of Incyte, effective 2026-02-10. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Feb 10, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Reid G. Hoffman executive of Incyte, effective 2026-02-10. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Feb 10, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Soni Basi executive of Incyte, effective 2026-02-10. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Feb 10, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | Steven Stein executive of Incyte, effective 2026-02-10. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Feb 10, 2026 | Oct 16, 2026 | Not yet signed | Not yet signed | William J. Meury executive of Incyte, effective 2026-02-10. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2025 | Oct 16, 2026 | Not yet signed | Not yet signed | William J. Meury seat on Incyte, effective 2025-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2021 | Oct 16, 2026 | Not yet signed | Not yet signed | Otis W. Brawley seat on Incyte, effective 2021-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2020 | Oct 16, 2026 | Not yet signed | Not yet signed | Katherine A. High, M.D. seat on Incyte, effective 2020-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2020 | Oct 16, 2026 | Not yet signed | Not yet signed | Katherine A. High, M.D. member of Science and Technology, effective 2020-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2019 | Oct 16, 2026 | Not yet signed | Not yet signed | Edmund P. Harrigan, M.D. seat on Incyte, effective 2019-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2019 | Oct 16, 2026 | Not yet signed | Not yet signed | Science and Technology · Chair; Audit and Finance committee of Incyte, effective 2019-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2019 | Oct 16, 2026 | Not yet signed | Not yet signed | Edmund P. Harrigan, M.D. member of Science and Technology · Chair; Audit and Finance, effective 2019-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2017 | Oct 16, 2026 | Not yet signed | Not yet signed | Jacqualyn A. Fouse, Ph.D. seat on Incyte, effective 2017-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2017 | Oct 16, 2026 | Not yet signed | Not yet signed | Audit and Finance; Nominating and Corporate Governance committee of Incyte, effective 2017-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2017 | Oct 16, 2026 | Not yet signed | Not yet signed | Jacqualyn A. Fouse, Ph.D. member of Audit and Finance; Nominating and Corporate Governance, effective 2017-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2015 | Oct 16, 2026 | Not yet signed | Not yet signed | Jean-Jacques Bienaim seat on Incyte, effective 2015-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2015 | Oct 16, 2026 | Not yet signed | Not yet signed | Paul J. Clancy seat on Incyte, effective 2015-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2015 | Oct 16, 2026 | Not yet signed | Not yet signed | Audit and Finance · Chair; Compensation committee of Incyte, effective 2015-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2015 | Oct 16, 2026 | Not yet signed | Not yet signed | Paul J. Clancy member of Audit and Finance · Chair; Compensation, effective 2015-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2001 | Oct 16, 2026 | Not yet signed | Not yet signed | Julian C. Baker seat on Incyte, effective 2001-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2001 | Oct 16, 2026 | Not yet signed | Not yet signed | Julian C. Baker chairs board Incyte, effective 2001-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2001 | Oct 16, 2026 | Not yet signed | Not yet signed | Nominating and Corporate Governance · Chair; Compensation committee of Incyte, effective 2001-01-01. |
| vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | Jan 1, 2001 | Oct 16, 2026 | Not yet signed | Not yet signed | Julian C. Baker chairs Nominating and Corporate Governance · Chair; Compensation, effective 2001-01-01. |
Access, rights, and the public-role doctrine
Facts are open. Rights travel with every Claim and every Evidence record, so an agent sees the same terms whichever format it reads.
| Capability | Access | Agents |
|---|---|---|
| Alpha Disclosure sample | public | human process |
| Alpha public website | public | retrievable now |
| Alpha Standard, methodology, and research | public | retrievable now |
| Alpha Profiles (public executive and company records) | public | retrievable now |
| Public HTTP endpoints described by OpenAPI 3.1 | public | retrievable now |
| Alpha MCP public discovery and read-only capabilities | public | retrievable now |
| Alpha AI Readiness Eval | public | human process |
| Alpha Platform | approved access | requires approved access |
| Alpha API (authenticated operations) | approved access | requires approved access |
| Alpha MCP premium capabilities | approved access | requires approved access |
| Alpha Evals and verified assessments | custom | human process |
| Alpha Council membership | custom | human process |
| Alpha Institute education, workshops, and coaching | custom | human process |
| Governance diagnostics and institutional advisory | custom | human process |
Record limitations. Every representation states these in the same words; nothing is inferred as zero.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
"rights": {
"public_retrieval": "allowed",
"agent_retrieval": "allowed",
"redistribution": "not_granted",
"model_training": "not_granted",
"commercial_use": "not_specified",
"relationship_pathfinding": "not_granted",
"direct_contact": "not_granted"
}
"evidence_rights": {
"evidence_records": 16,
"redistribution_allowed": 0,
"restricted_or_unknown": 16,
"classified_unknown": 16
}"data_subject": {
"basis": "public_record",
"entity": "alpha:company:590d6dea-9be2-46bc-8fbc-41ed972808f7",
"identity_ownership": "unclaimed",
"rights": {
"public_retrieval": "allowed",
"agent_retrieval": "allowed",
"redistribution": "not_granted",
"model_training": "not_granted",
"commercial_use": "not_specified",
"relationship_pathfinding": "not_granted",
"direct_contact": "not_granted"
},
"requests": "https://www.alpha.ac/contact"
}How agents find this
OpenThe page head and every response carry rel="alternate" links and the Registry's Link header. The list below is generated from the same list the server emits.
/.well-known/ai-catalog.jsonAlpha Agentic Resource Discovery manifest/.well-known/api-catalogapi-catalog/.well-known/webmcp.jsonAlpha WebMCP tool discovery/openapi.jsonAlpha Governance Public Intelligence API (OpenAPI 3.1)/apiAlpha Intelligence API/developersAlpha Governance Developer Platform/docs/trustcheck-receipts-v01.mdTrustCheck and Governance Receipts v0.1 test preview/docs/apiAlpha service documentation/llms.txtAlpha service docs for AI agents/agents.mdAlpha agent instructions (when to use Alpha)/api-versioning.mdAlpha public API versioning and deprecation policy/.well-known/agent-skills/index.jsonAgent Skills Index/products/accessAlpha Access and Availability/api/public/product-accessAlpha Product Access and Availability JSON/api/public/auth-capabilitiesAlpha Authentication Capabilities JSON/peopleAlpha Executive Profiles/companiesAlpha Company Profiles/people/readinessAlpha Profile Coverage and Agent Readiness/api/public/profile-readinessAlpha Public Profile Readiness JSON/api/public/profiles/steven-wolfe-pereiraAlpha Public Profile JSON Example/.well-known/agent-card.jsonA2A Agent Card/.well-known/mcp/server-card.jsonMCP Server Card/.well-known/openid-configurationOpenID Configuration/.well-known/oauth-protected-resourceOAuth Protected Resource/.well-known/oauth-authorization-serverOAuth Authorization Server (agent_auth)/.well-known/agent-registrationAgent Registration/.well-known/http-message-signatures-directoryhttp-message-signatures-directory/.well-known/jwks-rotationJWKS Rotation Policy/auth.mdAgent Authentication/llms.txtSite overview for AI agents/sitemap.xmlsitemap/api/public/agent-readinessAgent Readiness Status/api/public/company-report/osw-market-dataOSW Market Data Verification
Record map and assertion states
| Section | Anchor | Resource | State | Claims |
|---|---|---|---|---|
| Identity | #c-subject | /identity | Published | 0 |
| Corporate structure | - | /corporate_structure | Not reviewed | - |
| Board | #c-board | /board | Published | 8 |
| Committees | #c-committees | /committees | Published | 15 |
| Leadership | #c-leadership | /leadership | Published | 11 |
| Ownership | #c-control | /ownership | Not reviewed | 0 |
| Financials | #c-financials | /financials | Not reviewed | 2 |
| Capital structure | - | /capital_structure | Published | - |
| Compensation | #c-comp | /compensation | Not reviewed | 0 |
| Governance | #c-governance | /governance | Not reviewed | 0 |
| Shareholder governance | - | /shareholder_governance | Not reviewed | - |
| Audit | - | /audit | Not reviewed | - |
| Legal | #c-legal | /legal | Not reviewed | 0 |
| Risk | #c-risk | /risk | Not reviewed | 0 |
| Cyber | - | /cyber | Not reviewed | - |
| AI governance | #c-ai | /ai_governance | Not reviewed | 0 |
| Agent governance | #c-authority | /agent_governance | Restricted | 0 |
| Markets external | - | /markets_external | Published | - |
| Events | #c-history | /events | Published | 28 |
| Relationships | #c-links | /relationships | Published | 20 |
| Assessments | #c-monitor | /assessments | Published | 0 |
| Evidence | #c-evidence | /evidence | Published | 16 |
- corroboratedTwo or more independent sources agree
- source_reportedOne cited source states it
- alpha_inferenceAlpha's conclusion, with reasoning
- not_disclosedSearched, nothing found. Never rendered as false
- not_reviewedNot yet searched
- not_registeredNo authority registered with Alpha



